Evaluating the Effects of Snack Products on Energy
2013年5月6日 更新者:Mondelēz International, Inc.
To determine the effect of snack products varying in composition, on energy in healthy adult subjects.
調査の概要
研究の種類
介入
入学 (実際)
49
段階
- 適用できない
連絡先と場所
このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。
研究場所
-
-
Georgia
-
Atlanta、Georgia、アメリカ、30341
- Mercer University Center for Clinical Research
-
-
参加基準
研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。
適格基準
就学可能な年齢
20年~45年 (大人)
健康ボランティアの受け入れ
はい
受講資格のある性別
全て
説明
Inclusion Criteria:
- The subject must provide informed consent.
- The subject is male or female, and between the ages of 20 and 45, inclusive.
- The subject is a routine, moderate daily user of caffeine (approximately 1-4 cups of coffee or equivalent).
- The subject is fluent in English.
- The subject has a minimum of a high school diploma.
- Females of Child-bearing Potential (FOCP) must have a negative urine or serum beta HCG pregnancy test at screening. FOCP must abstain from sexual activity that could result in a pregnancy, or use acceptable contraceptives throughout the period of study treatment exposure. Acceptable contraceptives include IUDs, hormonal contraceptives (oral, implanted or injectable) and double barrier methods (such as condom or diaphragm with spermicidal gel). If hormonal contraceptives are used, the period of use must be sufficiently long to achieve pharmacological effectiveness prior to study treatment exposure (refer to individual product information for details on onset of effectiveness). FOCP who are not currently sexually active, must agree to use acceptable contraception, as defined above, if they decide to become sexually active during the period of study treatment exposure .
- The subject is in good physical and mental health based on a general medical history.
- The subject has adequate visual and auditory acuity and cognitive ability to complete the assessments and is capable of understanding and following instructions for the performance tests within the normal, age-adjusted range (within one SD) at screening.
- Must be able and willing to obtain a minimum of 7 hours of sleep the night prior to each study visit.
- The subject is willing and able to comply with all requirements defined within this protocol.
- The subject reports having a snack at least two afternoons per week.
- The subject reports experiencing an "afternoon slump".
Exclusion Criteria
- The subject has a current Axis I or Axis II comorbid psychiatric diagnosis or other symptomatic manifestations that, in the opinion of the examining physician (Investigator), will contraindicate treatment with caffeine.
- Attention Deficit Disorder or Attention Deficit Hyperactivity Disorder
- BMI ≤ 19 or ≥ 30 kg/m2.
- The subject has documented allergies, adverse reactions, or intolerance to caffeine.
- The subject has any significant medical illness or condition for which caffeine is contraindicated.
- The subject has a history of drug dependence or substance use disorder based upon DSM-IV-TR criteria (excluding nicotine).
- The subject has a positive urine drug or alcohol drug test result (to include nicotine).
- The subject has participated in an investigational study or received an investigational drug within the past 28 days.
- The subject has used nicotine products within 30 days of screening or during the duration of the study.
- The subject is taking medications, that have CNS effects or affect performance, (such as sedating antihistamines and decongestant sympathomimetics, either oral or topical), and may interfere with efficacy or safety assessments.
- The subject has a concurrent chronic or acute illness (such as allergic rhinitis or severe cold), disability, or other condition that might confound the results of rating tests administered in the study or that might increase risk to the subject. Similarly, the subject will be excluded if he or she has any additional conditions that, in the Investigator's opinion, would preclude the subject from completing the study or would not be in the best interest of the subject. This would include any significant illness or unstable medical condition that could lead to difficulty complying with the protocol.
- The female subject is pregnant or lactating or planning on becoming pregnant during the study
- Hypertension or other chronic medical conditions
- Individuals who do not maintain a routine nighttime sleep schedule (e.g. no shift work).
- Individuals judged by the Investigator to be unsuitable for enrollment in this study for any reason.
- The subject has been diagnosed with phenylketonuria.
- Inability to perform performance tests within the Normal range (i.e., performance no lower than 1SD below the mean) at screening.
- The subject has a pre-existing medical condition.
- Subject has been diagnosed with a sleeping disorder.
- Subject has a fasting glucose of >110 mg/dl.
- Subject has an allergy to wheat, soy, nuts or other food.
- Subject has Kosher or Halal dietary restrictions.
- Subject reports never eating biscuits, cookies or crackers.
- Epworth Sleepiness Scale ≥ at screening (i.e., evidence of excessive daytime sleepiness).
- Dislike of chocolate flavorings
研究計画
このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:基礎科学
- 割り当て:ランダム化
- 介入モデル:クロスオーバー割り当て
- マスキング:ダブル
武器と介入
参加者グループ / アーム |
介入・治療 |
---|---|
プラセボコンパレーター:Control Food Product
Control food product
|
control food product
Experimental food product containing ingredient 1
Experimental food product containing ingredient 2
|
実験的:Experimental Food Product 1
Experimental food product 1
|
control food product
Experimental food product containing ingredient 1
Experimental food product containing ingredient 2
|
実験的:Experimental Food Product 2
Experimental food product 2
|
control food product
Experimental food product containing ingredient 1
Experimental food product containing ingredient 2
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
時間枠 |
---|---|
Energy questionnaire OR Rating of perceived energy OR Subjective feeling of energy (visual analog scale)
時間枠:90 minutes post snack
|
90 minutes post snack
|
協力者と研究者
ここでは、この調査に関係する人々や組織を見つけることができます。
捜査官
- 主任研究者:Chad VanDenBerg, Pharm.D.、Mercer University
研究記録日
これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。
主要日程の研究
研究開始
2012年2月1日
一次修了 (実際)
2012年8月1日
研究の完了 (実際)
2012年8月1日
試験登録日
最初に提出
2012年2月24日
QC基準を満たした最初の提出物
2012年2月29日
最初の投稿 (見積もり)
2012年3月6日
学習記録の更新
投稿された最後の更新 (見積もり)
2013年5月8日
QC基準を満たした最後の更新が送信されました
2013年5月6日
最終確認日
2013年5月1日
詳しくは
本研究に関する用語
その他の研究ID番号
- KFG-123X-01
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
Snack Productの臨床試験
-
Children's Hospital SrebrnjakBelupo; Podravka d.d.募集
-
Children's Hospital SrebrnjakBelupo; Podravka d.d.募集
-
Pennington Biomedical Research CenterSamsung完了